pAAV asyn S87A Citations (3)

Originally described in: Mimicking phosphorylation at serine 87 inhibits the aggregation of human alpha-synuclein and protects against its toxicity in a rat model of Parkinson's disease.
Oueslati A, Paleologou KE, Schneider BL, Aebischer P, Lashuel HA J Neurosci. 2012 Feb 1;32(5):1536-44. PubMed Journal

---

Articles Citing pAAV asyn S87A

Articles
Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases. Upadhyay A, Amanullah A, Mishra R, Kumar A, Mishra A. Mol Neurobiol. 2017 Jan 19. doi: 10.1007/s12035-016-0377-2. PubMed
Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation. Joshi V, Mishra R, Upadhyay A, Amanullah A, Poluri KM, Singh S, Kumar A, Mishra A. J Cell Physiol. 2019 Nov;234(11):20900-20914. doi: 10.1002/jcp.28695. Epub 2019 Apr 19. PubMed
Itraconazole Confers Cytoprotection Against Neurodegenerative Disease-Associated Abnormal Protein Aggregation. Dubey AR, Mishra R, Jagtap YA, Kinger S, Kumar P, Dhiman R, Ghosh S, Singh S, Prasad A, Jana NR, Mishra A. Mol Neurobiol. 2023 May;60(5):2397-2412. doi: 10.1007/s12035-023-03230-0. Epub 2023 Jan 19. PubMed

If you have published an article using this material, please email us at to have your article added to this page.